These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37653458)

  • 1. Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years: a feasibility study among North Carolina clinics.
    Vielot NA; Lane RM; Loefstedt K; Cunningham JL; Everson J; Tiller E; Johnson Patel SE; Smith JS
    Pilot Feasibility Stud; 2023 Aug; 9(1):153. PubMed ID: 37653458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years:  A pilot study among rural North Carolina clinics.
    Vielot N; Lane RM; Loefstedt K; Cunningham J; Everson J; Tiller E; Patel S; Smith J
    Res Sq; 2023 Jan; ():. PubMed ID: 36778244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation.
    Malo TL; Hall ME; Brewer NT; Lathren CR; Gilkey MB
    Implement Sci; 2018 Apr; 13(1):57. PubMed ID: 29673374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina.
    Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS
    Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers.
    Goessl CL; Christianson B; Hanson KE; Polter EJ; Olson SC; Boyce TG; Dunn D; Williams CL; Belongia EA; McLean HQ; VanWormer JJ
    BMC Public Health; 2022 Jul; 22(1):1322. PubMed ID: 35810274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing for active-duty Soldiers.
    Penick E; Grabert BK; Stockton E; Prentice-Dunn H; Ward M; Kirk T; Gilkey MB
    Hum Vaccin Immunother; 2022 Dec; 18(7):2153536. PubMed ID: 36539433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.
    Roland KB; Benard VB; Greek A; Hawkins NA; Saraiya M
    Vaccine; 2014 Sep; 32(42):5432-5. PubMed ID: 25131744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals.
    Kong WY; Huang Q; Thompson P; Grabert BK; Brewer NT; Gilkey MB
    Acad Pediatr; 2022; 22(4):573-580. PubMed ID: 35081470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
    Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
    Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Experience Recommending HPV Vaccination Before Age 11 Years.
    Biancarelli DL; Drainoni ML; Perkins RB
    J Pediatr; 2020 Feb; 217():92-97. PubMed ID: 31757474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics.
    Barnard JG; Marsh R; Anderson-Mellies A; Williams JL; Fisher MP; Cockburn MG; Dempsey AF; Cataldi JR
    Vaccine; 2022 Aug; 40(33):4835-4844. PubMed ID: 35792022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.
    Perkins RB; Clark JA; Apte G; Vercruysse JL; Sumner JJ; Wall-Haas CL; Rosenquist AW; Pierre-Joseph N
    Pediatrics; 2014 Sep; 134(3):e666-74. PubMed ID: 25136036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
    Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
    BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Glenn BA; Nonzee NJ; Tieu L; Pedone B; Cowgill BO; Bastani R
    Vaccine; 2021 Jun; 39(25):3435-3444. PubMed ID: 33992435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Primary Care Clinics' Experiences During Introduction of the 9-Valent HPV Vaccine.
    Kornides ML; Calo WA; Heisler-MacKinnon JA; Gilkey MB
    J Community Health; 2018 Apr; 43(2):291-296. PubMed ID: 28856551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States.
    Donahue KL; Hendrix KS; Sturm LA; Zimet GD
    Prev Med Rep; 2015; 2():892-898. PubMed ID: 26594616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.
    Islam JY; Hoyt AM; Ramos S; Morgan K; Kim CJ; de Sanjose S; Butera N; Senkomago V; Richter KL; McDonald MA; Vielot NA; Smith JS
    Cancer Causes Control; 2018 Nov; 29(11):1115-1130. PubMed ID: 30284670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.